A quiet residential property on the east side of Las Vegas became the focus of a high-level law enforcement investigation ...

Authorities are investigating a suspected biolaboratory found in a Las Vegas home linked to the owner of an unauthorized ...

Community members, energized by the Shut Down BioLab Coalition, are pressuring Rockdale County leaders to revoke BioLab's business license in response to a fire that released chemical-filled smoke.

Rockdale County will slap BioLab with a lawsuit following a chemical release and fire that erupted last month at a facility in Conyers, Georgia. During a press conference on Monday morning, county ...

As the massive smoke plume from Sunday’s chemical plant fire in Conyers continues to hover over Rockdale County and surrounding communities, residents have filed the first lawsuits seeking damages for ...

After a chemical fire at the Conyers BioLab facility impacted county residents and disrupted life and business, multiple lawsuits have been filed against the company. Adding to the various court cases ...

CONYERS, Ga. — A chemical fire at BioLab over the weekend is reigniting concerns about its safety record in Conyers. "One time? OK, we get it. But the second, third time — at what point do the ...

The U.S. Chemical Safety and Hazard Investigation Board (CSB) has released an update on its investigation into the September 29 BioLab fire in Conyers, Georgia, that shrouded neighborhoods in chemical ...

Residents in Rockdale County are demanding action after a chemical fire at BioLab in Conyers released harmful chemicals, causing health issues and business closures. A public forum held by state ...

The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.

TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...

A Japan-based biotechnology company developing small-molecule therapeutics targeting protein–protein interactions (PPIs).